Safety-Related Labeling Changes

The concomitant use of ciprofloxacin with methotrexate is not recommended , Sleep-related breathing disorders, Severe cutaneous adverse reactions , Hepatobiliary disorders, Opioid Use Disorder (abuse and dependence)

Trade Name

Jylamvo

Updated Section

"4.4 Special warnings and precautions for use , 4.5. Interactions with other medicinal products"

Month

Aug,2023